ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valbazen Anthelmintic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28V13553
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Valbazen Anthelmintic Market Research Report 2023
BUY CHAPTERS

Global Valbazen Anthelmintic Market Research Report 2025

Code: QYRE-Auto-28V13553
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lasa Supergenerics Limited
Fredun Pharmaceuticals
Supharma Chem
Salius Pharma
Huazhong Pharmaceutical
Jiangsu Quality Horizons Pharmtech
Hubei Zhongjiachem Pharmaceutical
SUZHOU HOMESUN PHARMACEUTICAL
K.A. Malle Pharmaceutica
HUBEI KEYI PHARMACEUTICAL INDUSTRY

Valbazen Anthelmintic Market Size

The global market for Valbazen Anthelmintic was valued at US$ 199 million in the year 2024 and is projected to reach a revised size of US$ 334 million by 2031, growing at a CAGR of 7.8% during the forecast period.

Valbazen Anthelmintic Market

Valbazen Anthelmintic Market

Valbazen is a brand name for an anthelmintic (deworming) medication used to treat various internal parasites in animals, particularly livestock such as cattle, sheep, goats, and poultry. The active ingredient in Valbazen is albendazole, which is a broad-spectrum anthelmintic that works by disrupting the metabolism of the parasites, ultimately leading to their death.
The market for Valbazen Anthelmintic is influenced by several drivers. Valbazen is a widely used anthelmintic medication in the livestock and veterinary industry to treat internal parasitic infections in various animals. The demand for anthelmintic treatments like Valbazen is driven by several factors that contribute to the growth of the market:
Livestock Health and Productivity: The primary driver for the Valbazen Anthelmintic market is the need to maintain the health and productivity of livestock. Parasitic infections can lead to reduced growth rates, poor feed conversion, decreased milk production, and other negative impacts on animal health.
Parasite Control: The effectiveness of Valbazen in treating a broad spectrum of internal parasites, including gastrointestinal worms and liver flukes, makes it a valuable tool for controlling parasitic infestations that can harm animals and impact their performance.
Animal Welfare: Treating parasitic infections contributes to the overall well-being and welfare of animals by alleviating discomfort and preventing serious health issues caused by internal parasites.
Preventive Care: Anthelmintic treatments like Valbazen are often used preventively as part of herd health management programs to reduce the risk of parasitic infections and maintain the overall health of livestock populations.
Veterinary Recommendations: Veterinarians play a key role in recommending and prescribing anthelmintic treatments based on their expertise and assessments of the health status of animals.
Global Livestock Industry: The global demand for animal-derived products such as meat, milk, and eggs drives the need to maintain healthy livestock populations through effective parasite control.
Increasing Livestock Production: As the world population grows, the demand for livestock products is also increasing, creating a higher demand for effective animal health management.
Resistance Management: Developing resistance to existing anthelmintic treatments is a concern in the livestock industry. Valbazen can be used strategically to help manage resistance issues by providing an alternative treatment option.
Regulatory Compliance: Regulatory agencies often require regular deworming and parasite control in livestock production systems, contributing to the demand for effective anthelmintic products like Valbazen.
Farm Efficiency: Healthy animals are more efficient in converting feed into products like meat and milk. Anthelmintic treatments help maintain optimal farm efficiency and productivity.
Emerging Markets: As livestock production expands in developing regions, the demand for anthelmintic treatments to ensure animal health and productivity is likely to grow.
Research and Development: Continued research into animal health and parasitic infections leads to the development of improved anthelmintic formulations and treatment protocols.
Sustainable Livestock Practices: Maintaining animal health through anthelmintic treatments aligns with sustainable and ethical livestock production practices.
Animal Genetics: With advancements in animal genetics and breeding, the need for effective health management, including parasite control, becomes more critical to optimize genetic potential.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Valbazen Anthelmintic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valbazen Anthelmintic.
The Valbazen Anthelmintic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Valbazen Anthelmintic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valbazen Anthelmintic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Valbazen Anthelmintic Market Report

Report Metric Details
Report Name Valbazen Anthelmintic Market
Accounted market size in year US$ 199 million
Forecasted market size in 2031 US$ 334 million
CAGR 7.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company K.A. Malle Pharmaceutica, Lasa Supergenerics Limited, Fredun Pharmaceuticals, Supharma Chem, Salius Pharma, HUBEI KEYI PHARMACEUTICAL INDUSTRY, Huazhong Pharmaceutical, Jiangsu Quality Horizons Pharmtech, Hubei Zhongjiachem Pharmaceutical, Suzhou Homesun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Valbazen Anthelmintic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Valbazen Anthelmintic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Valbazen Anthelmintic Market growing?

Ans: The Valbazen Anthelmintic Market witnessing a CAGR of 7.8% during the forecast period 2025-2031.

What is the Valbazen Anthelmintic Market size in 2031?

Ans: The Valbazen Anthelmintic Market size in 2031 will be US$ 334 million.

Who are the main players in the Valbazen Anthelmintic Market report?

Ans: The main players in the Valbazen Anthelmintic Market are K.A. Malle Pharmaceutica, Lasa Supergenerics Limited, Fredun Pharmaceuticals, Supharma Chem, Salius Pharma, HUBEI KEYI PHARMACEUTICAL INDUSTRY, Huazhong Pharmaceutical, Jiangsu Quality Horizons Pharmtech, Hubei Zhongjiachem Pharmaceutical, Suzhou Homesun Pharmaceutical

What are the Application segmentation covered in the Valbazen Anthelmintic Market report?

Ans: The Applications covered in the Valbazen Anthelmintic Market report are Human Use, Veterinary Use

What are the Type segmentation covered in the Valbazen Anthelmintic Market report?

Ans: The Types covered in the Valbazen Anthelmintic Market report are Tablet, Capsule

Recommended Reports

Anthelmintic Drug Markets

Veterinary Dewormers

Parasite Prevention

1 Valbazen Anthelmintic Market Overview
1.1 Product Definition
1.2 Valbazen Anthelmintic by Type
1.2.1 Global Valbazen Anthelmintic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Valbazen Anthelmintic by Application
1.3.1 Global Valbazen Anthelmintic Market Value by Application (2024 VS 2031)
1.3.2 Human Use
1.3.3 Veterinary Use
1.4 Global Valbazen Anthelmintic Market Size Estimates and Forecasts
1.4.1 Global Valbazen Anthelmintic Revenue 2020-2031
1.4.2 Global Valbazen Anthelmintic Sales 2020-2031
1.4.3 Global Valbazen Anthelmintic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Valbazen Anthelmintic Market Competition by Manufacturers
2.1 Global Valbazen Anthelmintic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Valbazen Anthelmintic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Valbazen Anthelmintic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Valbazen Anthelmintic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valbazen Anthelmintic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valbazen Anthelmintic, Product Type & Application
2.7 Global Key Manufacturers of Valbazen Anthelmintic, Date of Enter into This Industry
2.8 Global Valbazen Anthelmintic Market Competitive Situation and Trends
2.8.1 Global Valbazen Anthelmintic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Valbazen Anthelmintic Players Market Share by Revenue
2.8.3 Global Valbazen Anthelmintic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Valbazen Anthelmintic Market Scenario by Region
3.1 Global Valbazen Anthelmintic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Valbazen Anthelmintic Sales by Region: 2020-2031
3.2.1 Global Valbazen Anthelmintic Sales by Region: 2020-2025
3.2.2 Global Valbazen Anthelmintic Sales by Region: 2026-2031
3.3 Global Valbazen Anthelmintic Revenue by Region: 2020-2031
3.3.1 Global Valbazen Anthelmintic Revenue by Region: 2020-2025
3.3.2 Global Valbazen Anthelmintic Revenue by Region: 2026-2031
3.4 North America Valbazen Anthelmintic Market Facts & Figures by Country
3.4.1 North America Valbazen Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Valbazen Anthelmintic Sales by Country (2020-2031)
3.4.3 North America Valbazen Anthelmintic Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valbazen Anthelmintic Market Facts & Figures by Country
3.5.1 Europe Valbazen Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Valbazen Anthelmintic Sales by Country (2020-2031)
3.5.3 Europe Valbazen Anthelmintic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valbazen Anthelmintic Market Facts & Figures by Region
3.6.1 Asia Pacific Valbazen Anthelmintic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Valbazen Anthelmintic Sales by Region (2020-2031)
3.6.3 Asia Pacific Valbazen Anthelmintic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Valbazen Anthelmintic Market Facts & Figures by Country
3.7.1 Latin America Valbazen Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Valbazen Anthelmintic Sales by Country (2020-2031)
3.7.3 Latin America Valbazen Anthelmintic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valbazen Anthelmintic Market Facts & Figures by Country
3.8.1 Middle East and Africa Valbazen Anthelmintic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Valbazen Anthelmintic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Valbazen Anthelmintic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valbazen Anthelmintic Sales by Type (2020-2031)
4.1.1 Global Valbazen Anthelmintic Sales by Type (2020-2025)
4.1.2 Global Valbazen Anthelmintic Sales by Type (2026-2031)
4.1.3 Global Valbazen Anthelmintic Sales Market Share by Type (2020-2031)
4.2 Global Valbazen Anthelmintic Revenue by Type (2020-2031)
4.2.1 Global Valbazen Anthelmintic Revenue by Type (2020-2025)
4.2.2 Global Valbazen Anthelmintic Revenue by Type (2026-2031)
4.2.3 Global Valbazen Anthelmintic Revenue Market Share by Type (2020-2031)
4.3 Global Valbazen Anthelmintic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Valbazen Anthelmintic Sales by Application (2020-2031)
5.1.1 Global Valbazen Anthelmintic Sales by Application (2020-2025)
5.1.2 Global Valbazen Anthelmintic Sales by Application (2026-2031)
5.1.3 Global Valbazen Anthelmintic Sales Market Share by Application (2020-2031)
5.2 Global Valbazen Anthelmintic Revenue by Application (2020-2031)
5.2.1 Global Valbazen Anthelmintic Revenue by Application (2020-2025)
5.2.2 Global Valbazen Anthelmintic Revenue by Application (2026-2031)
5.2.3 Global Valbazen Anthelmintic Revenue Market Share by Application (2020-2031)
5.3 Global Valbazen Anthelmintic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 K.A. Malle Pharmaceutica
6.1.1 K.A. Malle Pharmaceutica Company Information
6.1.2 K.A. Malle Pharmaceutica Description and Business Overview
6.1.3 K.A. Malle Pharmaceutica Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 K.A. Malle Pharmaceutica Valbazen Anthelmintic Product Portfolio
6.1.5 K.A. Malle Pharmaceutica Recent Developments/Updates
6.2 Lasa Supergenerics Limited
6.2.1 Lasa Supergenerics Limited Company Information
6.2.2 Lasa Supergenerics Limited Description and Business Overview
6.2.3 Lasa Supergenerics Limited Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lasa Supergenerics Limited Valbazen Anthelmintic Product Portfolio
6.2.5 Lasa Supergenerics Limited Recent Developments/Updates
6.3 Fredun Pharmaceuticals
6.3.1 Fredun Pharmaceuticals Company Information
6.3.2 Fredun Pharmaceuticals Description and Business Overview
6.3.3 Fredun Pharmaceuticals Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Fredun Pharmaceuticals Valbazen Anthelmintic Product Portfolio
6.3.5 Fredun Pharmaceuticals Recent Developments/Updates
6.4 Supharma Chem
6.4.1 Supharma Chem Company Information
6.4.2 Supharma Chem Description and Business Overview
6.4.3 Supharma Chem Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Supharma Chem Valbazen Anthelmintic Product Portfolio
6.4.5 Supharma Chem Recent Developments/Updates
6.5 Salius Pharma
6.5.1 Salius Pharma Company Information
6.5.2 Salius Pharma Description and Business Overview
6.5.3 Salius Pharma Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Salius Pharma Valbazen Anthelmintic Product Portfolio
6.5.5 Salius Pharma Recent Developments/Updates
6.6 HUBEI KEYI PHARMACEUTICAL INDUSTRY
6.6.1 HUBEI KEYI PHARMACEUTICAL INDUSTRY Company Information
6.6.2 HUBEI KEYI PHARMACEUTICAL INDUSTRY Description and Business Overview
6.6.3 HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Product Portfolio
6.6.5 HUBEI KEYI PHARMACEUTICAL INDUSTRY Recent Developments/Updates
6.7 Huazhong Pharmaceutical
6.7.1 Huazhong Pharmaceutical Company Information
6.7.2 Huazhong Pharmaceutical Description and Business Overview
6.7.3 Huazhong Pharmaceutical Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huazhong Pharmaceutical Valbazen Anthelmintic Product Portfolio
6.7.5 Huazhong Pharmaceutical Recent Developments/Updates
6.8 Jiangsu Quality Horizons Pharmtech
6.8.1 Jiangsu Quality Horizons Pharmtech Company Information
6.8.2 Jiangsu Quality Horizons Pharmtech Description and Business Overview
6.8.3 Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Product Portfolio
6.8.5 Jiangsu Quality Horizons Pharmtech Recent Developments/Updates
6.9 Hubei Zhongjiachem Pharmaceutical
6.9.1 Hubei Zhongjiachem Pharmaceutical Company Information
6.9.2 Hubei Zhongjiachem Pharmaceutical Description and Business Overview
6.9.3 Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Product Portfolio
6.9.5 Hubei Zhongjiachem Pharmaceutical Recent Developments/Updates
6.10 Suzhou Homesun Pharmaceutical
6.10.1 Suzhou Homesun Pharmaceutical Company Information
6.10.2 Suzhou Homesun Pharmaceutical Description and Business Overview
6.10.3 Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Product Portfolio
6.10.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valbazen Anthelmintic Industry Chain Analysis
7.2 Valbazen Anthelmintic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valbazen Anthelmintic Production Mode & Process Analysis
7.4 Valbazen Anthelmintic Sales and Marketing
7.4.1 Valbazen Anthelmintic Sales Channels
7.4.2 Valbazen Anthelmintic Distributors
7.5 Valbazen Anthelmintic Customer Analysis
8 Valbazen Anthelmintic Market Dynamics
8.1 Valbazen Anthelmintic Industry Trends
8.2 Valbazen Anthelmintic Market Drivers
8.3 Valbazen Anthelmintic Market Challenges
8.4 Valbazen Anthelmintic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lasa Supergenerics Limited
Fredun Pharmaceuticals
Supharma Chem
Salius Pharma
Huazhong Pharmaceutical
Jiangsu Quality Horizons Pharmtech
Hubei Zhongjiachem Pharmaceutical
SUZHOU HOMESUN PHARMACEUTICAL
K.A. Malle Pharmaceutica
HUBEI KEYI PHARMACEUTICAL INDUSTRY
List of Tables
 Table 1. Global Valbazen Anthelmintic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Valbazen Anthelmintic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Valbazen Anthelmintic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Valbazen Anthelmintic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Valbazen Anthelmintic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Valbazen Anthelmintic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Valbazen Anthelmintic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Valbazen Anthelmintic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Valbazen Anthelmintic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Valbazen Anthelmintic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Valbazen Anthelmintic, Product Type & Application
 Table 12. Global Key Manufacturers of Valbazen Anthelmintic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Valbazen Anthelmintic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valbazen Anthelmintic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Valbazen Anthelmintic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Valbazen Anthelmintic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Valbazen Anthelmintic Sales Market Share by Region (2020-2025)
 Table 19. Global Valbazen Anthelmintic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Valbazen Anthelmintic Sales Market Share by Region (2026-2031)
 Table 21. Global Valbazen Anthelmintic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Valbazen Anthelmintic Revenue Market Share by Region (2020-2025)
 Table 23. Global Valbazen Anthelmintic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Valbazen Anthelmintic Revenue Market Share by Region (2026-2031)
 Table 25. North America Valbazen Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Valbazen Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Valbazen Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Valbazen Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Valbazen Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Valbazen Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Valbazen Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Valbazen Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Valbazen Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Valbazen Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Valbazen Anthelmintic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Valbazen Anthelmintic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Valbazen Anthelmintic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Valbazen Anthelmintic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Valbazen Anthelmintic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Valbazen Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Valbazen Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Valbazen Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Valbazen Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Valbazen Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Valbazen Anthelmintic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Valbazen Anthelmintic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Valbazen Anthelmintic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Valbazen Anthelmintic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Valbazen Anthelmintic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Valbazen Anthelmintic Sales (K Units) by Type (2020-2025)
 Table 51. Global Valbazen Anthelmintic Sales (K Units) by Type (2026-2031)
 Table 52. Global Valbazen Anthelmintic Sales Market Share by Type (2020-2025)
 Table 53. Global Valbazen Anthelmintic Sales Market Share by Type (2026-2031)
 Table 54. Global Valbazen Anthelmintic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Valbazen Anthelmintic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Valbazen Anthelmintic Revenue Market Share by Type (2020-2025)
 Table 57. Global Valbazen Anthelmintic Revenue Market Share by Type (2026-2031)
 Table 58. Global Valbazen Anthelmintic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Valbazen Anthelmintic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Valbazen Anthelmintic Sales (K Units) by Application (2020-2025)
 Table 61. Global Valbazen Anthelmintic Sales (K Units) by Application (2026-2031)
 Table 62. Global Valbazen Anthelmintic Sales Market Share by Application (2020-2025)
 Table 63. Global Valbazen Anthelmintic Sales Market Share by Application (2026-2031)
 Table 64. Global Valbazen Anthelmintic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Valbazen Anthelmintic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Valbazen Anthelmintic Revenue Market Share by Application (2020-2025)
 Table 67. Global Valbazen Anthelmintic Revenue Market Share by Application (2026-2031)
 Table 68. Global Valbazen Anthelmintic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Valbazen Anthelmintic Price (US$/Unit) by Application (2026-2031)
 Table 70. K.A. Malle Pharmaceutica Company Information
 Table 71. K.A. Malle Pharmaceutica Description and Business Overview
 Table 72. K.A. Malle Pharmaceutica Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. K.A. Malle Pharmaceutica Valbazen Anthelmintic Product
 Table 74. K.A. Malle Pharmaceutica Recent Developments/Updates
 Table 75. Lasa Supergenerics Limited Company Information
 Table 76. Lasa Supergenerics Limited Description and Business Overview
 Table 77. Lasa Supergenerics Limited Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Lasa Supergenerics Limited Valbazen Anthelmintic Product
 Table 79. Lasa Supergenerics Limited Recent Developments/Updates
 Table 80. Fredun Pharmaceuticals Company Information
 Table 81. Fredun Pharmaceuticals Description and Business Overview
 Table 82. Fredun Pharmaceuticals Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Fredun Pharmaceuticals Valbazen Anthelmintic Product
 Table 84. Fredun Pharmaceuticals Recent Developments/Updates
 Table 85. Supharma Chem Company Information
 Table 86. Supharma Chem Description and Business Overview
 Table 87. Supharma Chem Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Supharma Chem Valbazen Anthelmintic Product
 Table 89. Supharma Chem Recent Developments/Updates
 Table 90. Salius Pharma Company Information
 Table 91. Salius Pharma Description and Business Overview
 Table 92. Salius Pharma Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Salius Pharma Valbazen Anthelmintic Product
 Table 94. Salius Pharma Recent Developments/Updates
 Table 95. HUBEI KEYI PHARMACEUTICAL INDUSTRY Company Information
 Table 96. HUBEI KEYI PHARMACEUTICAL INDUSTRY Description and Business Overview
 Table 97. HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HUBEI KEYI PHARMACEUTICAL INDUSTRY Valbazen Anthelmintic Product
 Table 99. HUBEI KEYI PHARMACEUTICAL INDUSTRY Recent Developments/Updates
 Table 100. Huazhong Pharmaceutical Company Information
 Table 101. Huazhong Pharmaceutical Description and Business Overview
 Table 102. Huazhong Pharmaceutical Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Huazhong Pharmaceutical Valbazen Anthelmintic Product
 Table 104. Huazhong Pharmaceutical Recent Developments/Updates
 Table 105. Jiangsu Quality Horizons Pharmtech Company Information
 Table 106. Jiangsu Quality Horizons Pharmtech Description and Business Overview
 Table 107. Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Jiangsu Quality Horizons Pharmtech Valbazen Anthelmintic Product
 Table 109. Jiangsu Quality Horizons Pharmtech Recent Developments/Updates
 Table 110. Hubei Zhongjiachem Pharmaceutical Company Information
 Table 111. Hubei Zhongjiachem Pharmaceutical Description and Business Overview
 Table 112. Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hubei Zhongjiachem Pharmaceutical Valbazen Anthelmintic Product
 Table 114. Hubei Zhongjiachem Pharmaceutical Recent Developments/Updates
 Table 115. Suzhou Homesun Pharmaceutical Company Information
 Table 116. Suzhou Homesun Pharmaceutical Description and Business Overview
 Table 117. Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Suzhou Homesun Pharmaceutical Valbazen Anthelmintic Product
 Table 119. Suzhou Homesun Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Valbazen Anthelmintic Distributors List
 Table 123. Valbazen Anthelmintic Customers List
 Table 124. Valbazen Anthelmintic Market Trends
 Table 125. Valbazen Anthelmintic Market Drivers
 Table 126. Valbazen Anthelmintic Market Challenges
 Table 127. Valbazen Anthelmintic Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Valbazen Anthelmintic
 Figure 2. Global Valbazen Anthelmintic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Valbazen Anthelmintic Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Global Valbazen Anthelmintic Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Valbazen Anthelmintic Market Share by Application: 2024 & 2031
 Figure 8. Human Use
 Figure 9. Veterinary Use
 Figure 10. Global Valbazen Anthelmintic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Valbazen Anthelmintic Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Valbazen Anthelmintic Sales (2020-2031) & (K Units)
 Figure 13. Global Valbazen Anthelmintic Average Price (US$/Unit) & (2020-2031)
 Figure 14. Valbazen Anthelmintic Report Years Considered
 Figure 15. Valbazen Anthelmintic Sales Share by Manufacturers in 2024
 Figure 16. Global Valbazen Anthelmintic Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Valbazen Anthelmintic Players: Market Share by Revenue in Valbazen Anthelmintic in 2024
 Figure 18. Valbazen Anthelmintic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Valbazen Anthelmintic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Valbazen Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 21. North America Valbazen Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 22. United States Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Valbazen Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 25. Europe Valbazen Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Valbazen Anthelmintic Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Valbazen Anthelmintic Revenue Market Share by Region (2020-2031)
 Figure 33. China Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Valbazen Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Valbazen Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Valbazen Anthelmintic Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Valbazen Anthelmintic Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Valbazen Anthelmintic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Valbazen Anthelmintic by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Valbazen Anthelmintic by Type (2020-2031)
 Figure 52. Global Valbazen Anthelmintic Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Valbazen Anthelmintic by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Valbazen Anthelmintic by Application (2020-2031)
 Figure 55. Global Valbazen Anthelmintic Price (US$/Unit) by Application (2020-2031)
 Figure 56. Valbazen Anthelmintic Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Albendazole Bolus Market Research Report 2024
Global Anthelmintic Fenbendazole Market Research Report 2024
Global Mebendazole Market Research Report 2024
Global Animal Internal Dewormer Market Insights Forecast to 2030
Global Farm Animal Internal Dewormer Market Insights Forecast to 2030
Global Oxfendazole Market Research Report 2024
Global Animal Dewormer Market Insights Forecast to 2030
Global Ricobendazole Market Research Report 2024
Global Livestock Internal Dewormer Market Insights Forecast to 2030
Albendazole Anthelmintic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Albendazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Albendazole Tablets Market Research Report 2024
Global Livestock External Dewormer Market Insights Forecast to 2030
Global Livestock Dewormers Market Insights Forecast to 2030
Global Vermox Market Research Report 2024
Global Triclabendazole Market Research Report 2024
Albendazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Animal Anthelmintics Market Research Report 2024
Global Flubendazole Market Research Report 2024
Global In Vitro Deworming Medicine for Pets Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions